Sacituzumab Govitecan for the Treatment for Patients With Locally Advanced, Recurrent, or Metastatic Cholangiocarcinoma

Clinical trial NCT06178588 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06178588
Sponsor: University of Kansas Medical Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Locally Advanced Cholangiocarcinoma Metastatic Cholangiocarcinoma Recurrent Cholangiocarcinoma Stage III Hilar Cholangiocarcinoma AJCC v8 Stage III Intrahepatic Cholangiocarcinoma AJCC v8 Stage IV Hilar Cholangiocarcinoma AJCC v8 Stage IV Intrahepatic Cholangiocarcinoma AJCC v8

Start date: 2024-02-01
Primary completion: 2026-03-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.